Stocks were lower at the halfway point Thursday in volatile trading, with the Dow Industrials down more than 1,000 points over two days. The S&P 500 fell more than a percent, while the Nasdaq fared slightly better.
The tech-heavy index saw fractional declines a day after a rout in tech stocks marked the worst market drop in eight months. Major tech companies like Microsoft ($MSFT), Facebook ($FB), and Alphabet ($GOOGL) had rebounded from Wednesday's losses with slight gains.
The continued sell-off was due in part to concerns about tightening monetary policy. President Trump has broken from tradition and repeatedly criticized the Fed for raising interest rates. He continued to attack Fed Chair Jerome Powell Thursday, saying he was "disappointed" in "far too stringent" rate hike decisions.
Earlier in the day, stocks briefly turned positive before extending their losses.
Best Buy lowered its sales outlook for the rest of the year despite a positive quarterly earnings report.
X Corp, formerly known as Twitter, is facing over 2,200 arbitration cases.
Google Flight added a new feature that tracks flight prices.
Businesses posted far fewer open jobs in July and the number of Americans quitting their jobs fell sharply for the second straight month, clear signs that the labor market is cooling in a way that could reduce inflation.
American Airlines said it was fined $4.1 million for keeping passengers on planes during long on-ground delays.
3M said it will pay $6 billion to settle lawsuits claiming that it sold defective earplugs to the U.S. military.
Meta said it disrupted a campaign of disinformation linked to Chinese law enforcement.
Buying your first home can be challenging with rising interest rates and other costs. Cheddar News spoke with Amira Elgoneimy, a premiere agent with Redfin who caters to the New Brunswick, NJ area, and Daryl Fairweather, chief economist with Redfin, about the process involved in purchasing a residence in a competitive market.
Experts from Redfin real estate brokerage explain the challenges buyers are experiencing as they try to buy their first homes.
The Biden administration is targeting the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications for Medicare's first-ever drug price negotiations as it seeks to lower medical costs for Americans.
